Health & Fitness

According to FutureWise analysis the market for Interventional Oncology in 2023 was US$ 2.03 billion, and is expected to reach US$ 3.5 billion by 2031 at a CAGR of 7.02%. Interventional oncology involves the use of image guidance to perform minimally invasive medical procedures for the diagnosis, palliation, and treatment of various types of cancer. Techniques such as fluoroscopy, ultrasound, and computed tomography are employed in these procedures to target specific areas affected by cancer or pain. Interventional oncology is often combined with other cancer treatments, including chemotherapy, radiation therapy, and surgery. These procedures offer several advantages, such as shorter hospital stays, quicker recovery times, more precise treatments, and minimal side effects. Recent technological advancements in interventional oncology, the benefits of minimally invasive surgical procedures, and increased government funding have all contributed to the growth of this market.  The ... Continue reading →

North America & Europe microencapsulation market is estimated to grow 2.2x between 2023 and 2032 creating an absolute $ opportunity of more than USD 7,537.3 million. In 2021, the microencapsulation market declined and witnessed a YoY of 1.9 in 2021, compared to 6.7% of YoY in 2020. The pandemic has really shaken up global supply chains, making it harder to find the raw materials and ingredients needed for microencapsulation. But don’t worry. Thanks to some amazing technological advancements, the microencapsulation market is still thriving. We're seeing innovative techniques pop up, like dripping, emulsion, and spray methods, which allow for the creation of custom microcapsules tailored to specific needs. Plus, there's a growing trend towards using natural and sustainable coating materials. This shift is largely driven by consumers who are looking for eco-friendly and clean-label products. As we move forward, you can expect even more creativity in how these ... Continue reading →

According to FutureWise analysis the market for intravitreal (ivt) injectables in 2023 was US$ 15.7 billion, and is expected to reach US$ 27 billion by 2031 at a CAGR of 6.5%. Intravitreal injection is a medical procedure involving the administration of drugs directly into the eyeball through a fine needle. This technique allows medications to be delivered to the vitreous humor, the gel-like substance within the eye, which is effective in treating various eye conditions. These conditions include age-related macular degeneration (AMD), diabetic retinopathy, and intraocular infections such as endophthalmitis. Compared to topical treatments, intravitreal injections provide a more targeted approach to medication delivery. The needle can bypass several anatomical barriers like the cornea, conjunctiva, and lens, as well as dynamic barriers such as tears and aqueous humor. Additionally, this method can potentially minimize adverse effects on other body tissues, a concern that may ... Continue reading →

According to FutureWise analysis the market for Fecal Calprotectin Test in 2023 was US$ 68 Million, and is expected to reach US$ 160 Million by 2031 at a CAGR of 13.1%. The fecal calprotectin test is a valuable diagnostic tool that measures calprotectin, a protein associated with inflammation, in stool samples. Primarily found in white blood cells, elevated calprotectin levels indicate inflammation in the gastrointestinal tract, helping to diagnose inflammatory bowel diseases (IBD) like Crohn's disease and ulcerative colitis, while distinguishing them from disorders such as irritable bowel syndrome (IBS). This non-invasive test can be conducted in a doctor's office or at home with a special kit. Patients collect a stool sample and send it to a lab for analysis, with results typically available in just a few days. For home test kits, results can be ready in 15-30 minutes. However, it's important to note that the fecal calprotectin test isn't a standalone ... Continue reading →

The Asia-Pacific home-use infrared thermometer market was close to USD 550 Mn in 2023 and to grow at a CAGR of 8.1% through 2032. Infrared thermometers are remarkable tools that combine efficiency, accuracy, and reliability, making them indispensable in a variety of industries. Numerous companies are dedicated to delivering specialized solutions tailored to the unique needs of each sector. Moreover, built-in infrared thermometers play a vital role in automation and predictive maintenance, where monitoring temperature becomes essential for the upkeep and routine inspection of manufacturing tools. Their ability to enhance operational excellence makes them a crucial asset in today’s competitive landscape. Asia-Pacific home-use infrared thermometer market is segmented into Measurement Points, Sales Channels, and Countries. The Asia-Pacific market is estimated to grow 1.60x between 2024 and 2032 creating an absolute $ opportunity of more than USD 500+ Mn. In 2023-2024 the ... Continue reading →

North America & Europe complex granulation equipment market is estimated to grow 1.5x between 2024 and 2032 creating an absolute $ opportunity of more than USD 1,446.9 million. In 2021, the complex granulation equipment market declined and witnessed a YoY of 0.8% in 2021, compared to 3.5% of YoY in 2020. The pharmaceutical industry is undergoing a major change as more companies embrace continuous manufacturing methods. This shift is encouraged by supportive regulations and a focus on becoming more flexible, lowering costs, and improving the supply chain. Continuous granulation equipment plays a key role in this transformation by allowing different steps of the manufacturing process—like blending, granulation, drying, and coating—to happen seamlessly together. This not only streamlines operations but also helps cut down on waste. By making transitions smoother and reducing downtime, manufacturers can respond more quickly to market demands. Additionally, this ... Continue reading →

According to FutureWise analysis the market for drug screening in 2023 was US$ 7.3 billion, and is expected to reach US$ 24.43 billion by 2031 at a CAGR of 16.30%. Drug screening involves assessing individuals for drug use, even if they do not show signs of intoxication or a substance use disorder. This screening can be conducted systematically or randomly among certain groups, including students, athletes, and individuals on probation. During the drug screening process, various samples—such as urine, blood, breath, saliva, sweat, or hair—may be tested. Urine testing is the most commonly used method due to its non-invasive nature, speed, and ability to detect a wide range of drugs. It can identify drug use within 1 to 4 days, or even longer, depending on the drug. Blood testing is less common because it is invasive and can typically detect drugs only a few hours after use. Hair testing, although infrequent, can reveal drug use up to 100 days prior. Government agencies ... Continue reading →

According to FutureWise analysis the market for Clinical Mass Spectrometry in 2023 was US$ 1.23 billion, and is expected to reach over US$ 1.90 billion by 2031 at a CAGR of 6.40%. Clinical mass spectrometry is becoming increasingly prevalent in both research and specialized clinical laboratories, with its adoption in standard laboratories also on the rise. This analytical technique determines the composition of molecules in a sample by analysing the spectrum produced by its ions. Clinical mass spectrometry specifically utilizes this technology for diagnostic purposes, enabling medical laboratories to identify metabolic disorders, detect biomarkers or enzymes, and conduct toxicology tests. A clinical diagnostic mass spectrometer is capable of analysing multiple samples simultaneously for a variety of applications, making it an invaluable tool for diagnostic medical laboratories. Notably, recent advancements allow for the quantitative detection of low concentrations of proteins, ... Continue reading →

According to FutureWise analysis the market for point of care diagnostics in 2023 was US$ 43.34 billion, and is expected to reach US$ 72.92 billion by 2031 at a CAGR of 6.70%. Point-of-care diagnostics (POCT) is changing the game when it comes to medical testing by bringing the lab right to you! Whether you’re at your bedside in a hospital, visiting a busy clinic, at a community health center, or even your local pharmacy, you can get your tests done on the spot. No more waiting around for samples to be sent off to faraway labs! This fast and convenient method means you’ll get your results much quicker, allowing doctors to make decisions and start treatment right away. Plus, since the testing happens where you are, it makes the whole process less stressful. You get more personalized care, and it’s easier to ask questions and understand your results. It’s all about making healthcare more accessible and efficient for everyone. POCT is making waves in various ... Continue reading →

According to FutureWise analysis the market for Cell Isolation or Cell Separation in 2023 was US$ 10 billion, and is expected to reach around US$ 32 billion by 2031 at a CAGR of 16.30%. Cell isolation, also known as cell separation, is a technique used to sort cells from a large group into a specific population without contamination. Factors such as surface charge and adhesion, cell size and density, surface markers, and others play a crucial role in the cell separation process. These methods of cell isolation are vital for advancing cell-based treatments, ultimately enhancing treatment quality and improving clinical outcomes. The market for cell isolation and cell separation is being driven by several factors, including the rising incidence of chronic illnesses due to an aging population, technological advancements in cell isolation, an increased demand for biopharmaceuticals and personalized treatments, and a surge in stem cell research. Among various methods, magnetic cell ... Continue reading →